Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NHS
MedTech
Grail stock craters as Galleri trial fails to hit endpoint
Grail’s shares plummeted more than 45% after-hours Thursday as the medtech revealed a major trial of its Galleri test missed its primary endpoint.
Ben Adams
Feb 20, 2026 7:30am
Optellum tapped by NHS for AI-powered lung cancer diagnostic
Feb 2, 2026 8:55am
Eko rolls out AI-powered stethoscopes to UK clinics
Nov 6, 2023 11:23am
Flatiron expands oncology work to UK with collaboration deal
Jun 21, 2023 4:00pm
Abbott's FreeStyle Libre cuts HbA1c in UK study
Oct 6, 2022 2:00pm
AI predicts lung cancer tumor growth after radiation: NHS study
Apr 25, 2022 11:41am
